This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

Karen Burton Biography and Net Worth

CAO of STERIS

Karen Louise Burton occupies the position of Chief Accounting Officer, VP & Controller of STERIS Plc (Ireland) and Controller & Vice President at STERIS Corp. and Chief Accounting Officer, Controller & VP at STERIS Ltd. (both are subsidiaries of STERIS Plc (Ireland)). Ms. Burton is also on the board of Framingham House Investments Ltd. and Gas Power Services Ltd.

What is Karen L. Burton's net worth?: The estimated net worth of Karen L. Burton is at least $2.35 million as of November 5th, 2020. Ms. Burton owns 10,746 shares of STERIS stock worth more than $2,351,977 as of December 2nd. This net worth evaluation does not reflect any other investments that Ms. Burton may own. Learn More about Karen L. Burton's net worth.
How old is Karen L. Burton?: Ms. Burton is currently 56 years old. There are 7 older executives and no younger executives at STERIS. The oldest executive at STERIS is Ms. Julia K. Madsen, Senior Vice President of Life Sciences, who is 59 years old. Learn More on Karen L. Burton's age.
How do I contact Karen L. Burton?: The corporate mailing address for Ms. Burton and other STERIS executives is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. STERIS can also be reached via phone at (440) 354-2600 and via email at [email protected]. Learn More on Karen L. Burton's contact information.
Has Karen L. Burton been buying or selling shares of STERIS?: Karen L. Burton has not been actively trading shares of STERIS within the last three months. Most recently, Karen L. Burton sold 4,000 shares of the business's stock in a transaction on Tuesday, March 29th. The shares were sold at an average price of $246.00, for a transaction totalling $984,000.00. Learn More on Karen L. Burton's trading history.
Who are STERIS's active insiders?: STERIS's insider roster includes Richard Breeden (Director), Karen Burton (CAO), Daniel Carestio (President, CEO & Director), Cynthia Feldmann (Director), Jacqueline Kosecoff (Director), David Lewis (Director), Julia Madsen (VP), Cary Majors (SVP), Walter Rosenbrough, Jr. (CEO), Mohsen Sohi (Director), Renato Tamaro (VP), Michael Tokich (CFO), and John Zangerle (VP). Learn More on STERIS's active insiders.
Are insiders buying or selling shares of STERIS?: In the last twelve months, insiders at the medical equipment provider sold shares 6 times. They sold a total of 33,249 shares worth more than $8,040,382.08. The most recent insider tranaction occured on November, 25th when SVP Cary L Majors sold 1,682 shares worth more than $365,532.24. Insiders at STERIS own 1.1% of the company. Learn More about insider trades at STERIS.
Information on this page was last updated on 11/25/2024.

Karen L. Burton Insider Trading History at STERIS

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/29/2022	Sell	4,000	$246.00	$984,000.00
2/15/2022	Sell	2,600	$232.61	$604,786.00
11/5/2020	Sell	4,602	$179.42	$825,690.84	10,746
6/3/2019	Sell	1,387	$133.89	$185,705.43
8/14/2018	Sell	1,300	$114.39	$148,707.00
5/11/2018	Sell	1,204	$102.74	$123,698.96
2/13/2018	Sell	1,500	$85.59	$128,385.00
8/15/2017	Sell	3,270	$85.70	$280,239.00	11,807

Karen L. Burton Buying and Selling Activity at STERIS

STERIS Company Overview

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Today's Range

Now: $218.54

$216.98

$219.04

50 Day Range

MA: $224.60

$211.98

$242.54

2 Week Range

Now: $218.54

$195.50

$248.24

Volume

174,980 shs

Average Volume

496,255 shs

Market Capitalization

$21.57 billion

P/E Ratio

49.89

Dividend Yield

1.04%

Beta

0.83

Missed Nvidia? Watch this ASAP

From Brownstone Research | Ad